vadimezan has been researched along with cyclic diadenosine phosphate in 2 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (cyclic diadenosine phosphate) | Trials (cyclic diadenosine phosphate) | Recent Studies (post-2010) (cyclic diadenosine phosphate) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 6 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikek, CG; Sintim, HO; Sooreshjani, MA; Wang, M | 1 |
| Bai, H; Gao, Y; Geng, M; Li, Z; Niu, J; Wang, X; Xie, Z; Xu, Y; Yang, Y; Zhang, Y; Zhou, B | 1 |
1 review(s) available for vadimezan and cyclic diadenosine phosphate
| Article | Year |
|---|---|
Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules.
Topics: | 2019 |
1 other study(ies) available for vadimezan and cyclic diadenosine phosphate
| Article | Year |
|---|---|
Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration.
Topics: 14-alpha Demethylase Inhibitors; Humans; Imidazoles; Immunity, Innate; Immunotherapy; Membrane Proteins; Neoplasms | 2022 |